- Filed
- Oct 31, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Oct 31, 2025 | 812.19M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 822.7M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 815.8M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 798.6M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 793.6M sh |
| Dividends Paid | Q3 2025 · Sep 30, 2025 | $643.3M |
| Dividends Paid | Q3 2025 · Sep 30, 2025 | $1.75B |
| Dividends Paid | Q3 2025 · Sep 30, 2024 | $468.8M |
| Dividends Paid | Q3 2025 · Sep 30, 2024 | $1.09B |
| Capex | Q3 2025 · Sep 30, 2025 | $349.2M |
| Capex | Q3 2025 · Sep 30, 2025 | $902.7M |
| Capex | Q3 2025 · Sep 30, 2024 | $246.4M |
| Capex | Q3 2025 · Sep 30, 2024 | $792M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | $1.56B |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | $3.26B |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | $1.44B |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | $3.06B |
| Long Term Debt | Q3 2025 · Sep 30, 2025 | $6.75B |
| Long Term Debt | Q3 2025 · Dec 31, 2024 | $5.76B |
| Short Term Investments | Q3 2025 · Sep 30, 2025 | $575.9M |
| Short Term Investments | Q3 2025 · Dec 31, 2024 | $245.3M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $3.95B |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $3.26B |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $10.45B |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $9.17B |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $1.7B |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $2.25B |
| Current Assets | Q3 2025 · Sep 30, 2025 | $7.67B |
| Current Assets | Q3 2025 · Dec 31, 2024 | $6.17B |
| Total Assets | Q3 2025 · Sep 30, 2025 | $20.33B |
| Total Assets | Q3 2025 · Dec 31, 2024 | $18.71B |
| Total Assets | Q3 2025 · Sep 30, 2024 | $18.42B |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $1.35 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $3.71 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | $1.12 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | $3.25 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $1.35 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $3.71 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | $1.12 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | $3.25 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $33.7M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $97.9M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $31.2M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $96M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $1.77B |
| Operating Income | Q3 2025 · Sep 30, 2025 | $4.89B |
| Operating Income | Q3 2025 · Sep 30, 2024 | $1.45B |
| Operating Income | Q3 2025 · Sep 30, 2024 | $4.25B |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $1.36B |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $3.89B |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $1.22B |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $3.63B |
| Revenue | Q3 2025 · Sep 30, 2025 | $3.38B |
| Revenue | Q3 2025 · Sep 30, 2025 | $9.55B |
| Revenue | Q3 2025 · Sep 30, 2024 | $2.93B |
| Revenue | Q3 2025 · Sep 30, 2024 | $8.65B |